Please login to the form below

Not currently logged in
Email:
Password:

M3 expands with acquisition of Vidal Group

Grows global operations to cover Europe and Latin America

M3M3, the healthcare services provider, has expanded its global operations with the acquisition of healthcare informatics firm Vidal Group.

In a move to complement its existing business activities across the UK, US and Asia, M3 is now set to support the growth of Vidal's services focusing on key markets in Europe and Latin America.

Vidal Group currently specialises in providing reference drug information for healthcare professionals, with online databases tailored to cover all the latest treatment information and medical advances.

Now part of the M3 network - which includes M3.com, MDLinx, Medigate, medlive.cn, M3Medical and Doctors.net.uk - the group will also offer market research, digital communications and clinical trials and recruitment services.

Aki Tomaru, board director and chief executive of M3 USA, said: “The addition of the Vidal Group to M3 marks a very significant and important step for M3 in its mission to deliver trusted and high quality medical information and services in key markets across the world to drive forward innovation, improved efficiency and better outcomes in healthcare.”

Article by
Rebecca Clifford

21st December 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...
white house
Eliminating pharmaceutical rebates, is this déjà vu?
By Andrew Parece and Matthew Majewski...
Patients are ready to embrace decentralised clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...

Infographics